This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San Diego

John McCafferty, PhD
Chief Technology Officer at Maxion Therapeutics
Speaker

Profile

John McCafferty was one of the founders of Cambridge Antibody Technology (CAT) and a co-inventor of antibody phage display. In 2012 he formed IONTAS who generated multiple drug leads currently in clinical trial by partner companies. During this period John developed KnotBodyTM technology to address ion channels, an important target class which are under-served by biologics. He founded Maxion Therapeutics to take advantage of this drug development opportunity. Interspersed with company formation John has held academic positions at the Wellcome Trust Sanger Institute and is currently an Affiliated professor at the Department of Medicine at the University of Cambridge.

John McCafferty, PhD's Network

Agenda Sessions

  • Blocking Ion Channel Kv1.3 with KnotBodyTM Molecules to Modulate T cell Function

    4:45pm